IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 242 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,960,369 | -75.2% | 203,569 | -72.5% | 0.00% | -76.5% |
| Q2 2023 | $7,888,911 | +10.2% | 741,439 | +8.9% | 0.02% | +6.2% |
| Q1 2023 | $7,160,985 | -12.3% | 680,702 | +3.3% | 0.02% | -15.8% |
| Q4 2022 | $8,167,451 | +36.8% | 659,197 | +14.4% | 0.02% | +26.7% |
| Q3 2022 | $5,971,000 | +14.4% | 576,388 | +27.3% | 0.02% | +25.0% |
| Q2 2022 | $5,219,000 | -8.3% | 452,672 | +0.1% | 0.01% | +9.1% |
| Q1 2022 | $5,689,000 | +13.7% | 452,191 | +5.4% | 0.01% | +22.2% |
| Q4 2021 | $5,004,000 | +13.6% | 429,131 | +27.2% | 0.01% | +12.5% |
| Q3 2021 | $4,406,000 | -25.7% | 337,365 | -26.8% | 0.01% | -20.0% |
| Q2 2021 | $5,929,000 | -1.9% | 460,688 | -14.8% | 0.01% | 0.0% |
| Q1 2021 | $6,042,000 | +53.6% | 540,473 | +56.5% | 0.01% | +42.9% |
| Q4 2020 | $3,934,000 | +53.6% | 345,367 | +21.3% | 0.01% | +75.0% |
| Q3 2020 | $2,561,000 | -43.7% | 284,715 | -35.4% | 0.00% | -42.9% |
| Q2 2020 | $4,550,000 | +67.4% | 440,921 | +63.7% | 0.01% | +40.0% |
| Q1 2020 | $2,718,000 | +38.8% | 269,390 | +83.1% | 0.01% | +150.0% |
| Q4 2019 | $1,958,000 | +336.1% | 147,113 | +181.6% | 0.00% | +100.0% |
| Q3 2019 | $449,000 | -72.6% | 52,243 | -65.1% | 0.00% | -50.0% |
| Q2 2019 | $1,640,000 | +128.1% | 149,888 | +181.9% | 0.00% | +100.0% |
| Q1 2019 | $719,000 | +257.7% | 53,169 | +297.1% | 0.00% | – |
| Q4 2017 | $201,000 | -53.7% | 13,389 | -51.3% | 0.00% | -100.0% |
| Q3 2017 | $434,000 | -58.2% | 27,498 | -50.0% | 0.00% | 0.0% |
| Q2 2017 | $1,039,000 | +10.6% | 55,047 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $939,000 | +32.3% | 55,047 | +18.6% | 0.00% | 0.0% |
| Q4 2016 | $710,000 | +10.8% | 46,418 | +15.1% | 0.00% | 0.0% |
| Q3 2016 | $641,000 | +118.0% | 40,343 | +65.8% | 0.00% | 0.0% |
| Q2 2015 | $294,000 | -64.2% | 24,338 | -52.6% | 0.00% | -50.0% |
| Q1 2015 | $822,000 | +5.0% | 51,400 | +0.6% | 0.00% | 0.0% |
| Q4 2014 | $783,000 | -2.4% | 51,100 | -17.4% | 0.00% | 0.0% |
| Q3 2014 | $802,000 | – | 61,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $157,835,700 | 21.26% |
| AlphaCentric Advisors LLC | 292,500 | $2,816,775 | 1.60% |
| Quantedge Capital Pte Ltd | 179,900 | $1,732,437 | 0.94% |
| Intrinsic Value Partners, LLC | 50,355 | $484,919 | 0.62% |
| Brown Capital Management | 3,719,796 | $35,821,635 | 0.55% |
| ARMISTICE CAPITAL, LLC | 3,456,000 | $33,281,280 | 0.51% |
| SummerHaven Investment Management, LLC | 67,765 | $652,577 | 0.48% |
| BRAIDWELL LP | 1,348,099 | $12,982,193 | 0.41% |
| AFFINITY INVESTMENT ADVISORS, LLC | 50,733 | $488,559 | 0.32% |
| EMC Capital Management | 43,315 | $417 | 0.31% |